Cost-effectiveness of routine COVID-19 adult vaccination programmes in England
View ORCID ProfileMatt J. Keeling, View ORCID ProfileEdward M. Hill, View ORCID ProfileStavros Petrou, Phuong Bich Tran, View ORCID ProfileMay Ee Png, View ORCID ProfileSophie Staniszewska, View ORCID ProfileCorinna Clark, Katie Hassel, View ORCID ProfileJulia Stowe, View ORCID ProfileNick Andrews
doi: https://doi.org/10.1101/2024.11.08.24316972
Matt J. Keeling
1The Zeeman Institute for Systems Biology & Infectious Disease Epidemiology Research, School of Life Sciences and Mathematics Institute, University of Warwick, Coventry, UK
Edward M. Hill
2Civic Health Innovation Labs and Institute of Population Health, University of Liverpool, Liverpool, UK
3NIHR Health Protection Research Unit in Gastrointestinal Infections, University of Liverpool, Liverpool, UK
Stavros Petrou
4Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Phuong Bich Tran
4Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
May Ee Png
4Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Sophie Staniszewska
5Warwick Medical School, University of Warwick, Coventry, UK
Corinna Clark
5Warwick Medical School, University of Warwick, Coventry, UK
Katie Hassel
6Immunisation Division, UK Health Security Agency, London, UK
Julia Stowe
6Immunisation Division, UK Health Security Agency, London, UK
Nick Andrews
6Immunisation Division, UK Health Security Agency, London, UK
Data availability
The raw study data are protected and are not available due to data privacy laws. This work is carried out under Regulation 3 of The Health Service (Control of Patient Information) (Secretary of State for Health, 2002) (3) using patient identification information without individual patient consent. Data cannot be made publicly available for ethical and legal reasons, i.e. public availability would compromise patient confidentiality as data tables list single counts of individuals rather than aggregated data.
Posted November 12, 2024.
Cost-effectiveness of routine COVID-19 adult vaccination programmes in England
Matt J. Keeling, Edward M. Hill, Stavros Petrou, Phuong Bich Tran, May Ee Png, Sophie Staniszewska, Corinna Clark, Katie Hassel, Julia Stowe, Nick Andrews
medRxiv 2024.11.08.24316972; doi: https://doi.org/10.1101/2024.11.08.24316972
Cost-effectiveness of routine COVID-19 adult vaccination programmes in England
Matt J. Keeling, Edward M. Hill, Stavros Petrou, Phuong Bich Tran, May Ee Png, Sophie Staniszewska, Corinna Clark, Katie Hassel, Julia Stowe, Nick Andrews
medRxiv 2024.11.08.24316972; doi: https://doi.org/10.1101/2024.11.08.24316972
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2918)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12711)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4567)
- Geriatric Medicine (415)
- Health Economics (726)
- Health Informatics (2913)
- Health Policy (1068)
- Hematology (386)
- HIV/AIDS (922)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (467)
- Neurology (4335)
- Nursing (234)
- Nutrition (636)
- Oncology (2261)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (499)
- Pediatrics (1196)
- Primary Care Research (494)
- Public and Global Health (6916)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (436)
- Sports Medicine (383)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (178)